Third Point’s Horizon Therapeutics HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
Third Point's HZNP Position: Q3 2023 in Review
Third Point sold out of Horizon Therapeutics (HZNP) in Q3 2023, closing a stake of 500,000 shares — an estimated $51.4M sold.
Third Point first reported a position in HZNP in Q2 2023 and held it in 1 quarter. The position peaked at $51.4M in Q2 2023. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.
- Third Point reported no remaining Horizon Therapeutics position as of Q3 2023 after selling out during the quarter.
- Third Point sold 500,000 Horizon Therapeutics shares in Q3 2023, an estimated $51.4M.
- Third Point first reported a position in Horizon Therapeutics in Q2 2023 and held it in 1 quarter.
- Third Point's Horizon Therapeutics position peaked at $51.4M in Q2 2023.
- 485 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q3 2023.
Based on Third Point's 13F filing for Q3 2023, filed 14 Nov 2023.